We see sustainability as a shared responsibility and a strategic imperative. It is not a destination, but a continuous journey of responsibility, innovation and impact. In line with our Blue Plan sustainability strategy, we pursue activities in three action areas: environment, people, and ethics. The structure is based on ESG reporting. The measures in these action areas reflect our commitment to minimizing environmental impact while supporting our customers’ sustainability goals. The boundaries between these action areas are inherently fluid. What is important is the holistic view of all our company’s areas of influence. Together, we are shaping a healthier, more sustainable future in healthcare and research.
Blue Plan has been the Greiner group’s sustainability strategy since 2020 and establishes the strategic framework for our activities and efforts for a sustainable future.
Dr. Mads Nybo, chief physician at the Clinical Biochemistry department of the Odense University Hospital shares his views on and experience with sustainability in the medical sector.
We explored the potential of circularity in the field of medical devices with Nermina Cuzovic, Expert Global Sustainability at Greiner Bio-One International. Nermina has a passion for protecting the planet and believes that sustainability is everyone's job.
Greiner Bio-One stands for values that customers can trust. Values that help customers on their way to a sustainable future, because this is what matters to us.
​By investing in the independently audited ACT® label from My Green Lab, we aim to provide our customers with the information they need to make eco-conscious choices. The ACT® label offers a clear and reliable assessment of the environmental impact of our products, helping you to make informed decisions that support a greener future. Explore our certified products and join us in our journey towards sustainability.
Would you like to stay on this page or do you want to switch to your local website?
